Activity-dependent shedding of heparin-binding EGF-like growth factor in brain neurons

Biochemical and Biophysical Research Communications

Volumn 348, Issue 3, 2006, Pages 963-970

  Shishido, Yuji ^a   Tanaka, Takayuki ^a   Piao, Ying shan ^a   Araki, Kazuaki ^a   Takei, Nobuyuki ^a   Higashiyama, Shigeki ^b   Nawa, Hiroyuki ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Department of Biochemistry and Molecular Genetics ^*  (Japan)

Author keywords

EGF; ErbB1; Glutamate; HB EGF; NMDA; Shedding; TACE

Indexed keywords

ALKALINE PHOSPHATASE; BOTULINUM TOXIN; CALCIUM CHELATING AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; ILOMASTAT; KAINIC ACID; KB R7785; METABOTROPIC RECEPTOR AGONIST; METALLOPROTEINASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID; NEUROTRANSMITTER; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN NERVE CELL; CELL CULTURE; CENTRAL NERVOUS SYSTEM; ENZYME INHIBITION; EXOCYTOSIS; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; MOUSE; NEOCORTEX; NEUROTRANSMISSION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SEIZURE; TRANSGENIC MOUSE;

ANIMALS; BRAIN; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; HEPARIN; HUMANS; MICE; MICE, TRANSGENIC; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; SYNAPTIC TRANSMISSION;

MUS MUSCULUS;

EID: 33747157696     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.129     Document Type: Article

References (40)

1. Iwamoto R., and Mekada E. ErbB and HB-EGF signaling in heart development and function. Cell Struct. Funct. 31 (2006) 1-14
2. Higashiyama S., and Nanba D. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk. Biochim. Biophys. Acta 1751 (2005) 110-117
3. Yamazaki S., Iwamoto R., Saeki K., Asakura M., Takashima S., Yamazaki A., Kimura R., Mizushima H., Moribe H., Higashiyama S., Endoh M., Kaneda Y., Takagi S., Itami S., Takeda N., Yamada G., and Mekada E. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J. Cell Biol. 163 (2003) 469-475
4. Umeda Y., Miyazaki Y., Shiinoki H., Higashiyama S., Nakanishi Y., and Hieda Y. Involvement of heparin-binding EGF-like growth factor and its processing by metalloproteinases in early epithelial morphogenesis of the submandibular gland. Dev. Biol. 237 (2001) 202-211
5. Tokumaru S., Higashiyama S., Endo T., Nakagawa T., Miyagawa J.I., Yamamori K., Hanakawa Y., Ohmoto H., Yoshino K., Shirakata Y., Matsuzawa Y., Hashimoto K., and Taniguchi N. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell Biol. 151 (2000) 209-220
6. Mishima K., Higashiyama S., Nagashima Y., Miyagi Y., Tamura A., Kawahara N., Taniguchi N., Asai A., Kuchino Y., and Kirino T. Regional distribution of heparin-binding epidermal growth factor-like growth factor mRNA and protein in adult rat forebrain. 1. J. Neurosci. Lett. 213 (1996) 153-156
7. Hayase Y., Higashiyama S., Sasahara M., Amano S., Nakagawa T., Taniguchi N., and Hazama F. Expression of heparin-binding epidermal growth factor-like growth factor in rat brain. Brain Res. 784 (1998) 163-178
8. Piao Y.S., Iwakura Y., Takei N., and Nawa H. Differential distributions of peptides in the epidermal growth factor family and phosphorylation of ErbB 1 receptor in adult rat brain. Neurosci. Lett. 390 (2005) 21-24
9. Nakagawa T., Sasahara M., Hayase Y., Haneda M., Yasuda H., Kikkawa R., Higashiyama S., and Hazama F. Neuronal and glial expression of heparin-binding EGF-like growth factor in central nervous system of prenatal and early-postnatal rat. Dev. Brain Res. 108 (1998) 263-272
10. Kornblum H.I., Zurcher S.D., Werb Z., Derynck R., and Seroogy K.B. Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system. Eur. J. Neurosci. 11 (1999) 3236-3246
11. Farkas L.M., and Krieglstein K. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons. J. Neural. Transm. 109 (2002) 267-277
12. Opanashuk L.A., Mark R.J., Porter J., Damm D., Mattson M.P., and Seroogy K.B. Heparin-binding epidermal growth factor-like growth factor in hippocampus: modulation of expression by seizures and anti-excitotoxic action. J. Neurosci. 19 (1999) 133-146
13. Sugiura S., Kitagawa K., Tanaka S., Todo K., Omura-Matsuoka E., Sasaki T., Mabuchi T., Matsushita K., Yagita Y., and Hori M. Adenovirus-mediated gene transfer of heparin-binding epidermal growth factor-like growth factor enhances neurogenesis and angiogenesis after focal cerebral ischemia in rats. Stroke 36 (2005) 859-864
14. Jin K., Mao X.O., Sun Y., Xie L., Jin L., Nishi E., Klagsbrun M., and Greenberg D.A. Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo. J. Neurosci. 22 (2002) 5365-7533
15. Higashiyama S., Abraham J.A., Miller J., Fiddes J.C., and Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251 (1991) 936-939
16. Goishi K., Higashiyama S., Klagsbrun M., Nakano N., Umata T., Ishikawa M., Mekada E., and Taniguchi N. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell. 6 (1995) 967-980
17. Izumi Y., Hirata M., Hasuwa H., Iwamoto R., Umata T., Miyado K., Tamai Y., Kurisaki T., Sehara-Fujisawa A., Ohno S., and Mekada E. A metalloproteinase-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17 (1998) 7260-7272
18. Iwamoto R., Handa K., and Mekada E. Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor. J. Biol. Chem. 274 (1999) 25906-25912
19. Miyoshi E., Higashiyama S., Nakagawa T., Hayashi N., and Taniguchi N. Membrane-anchored heparin-binding epidermal growth factor-like growth factor acts as a tumor survival factor in a hepatoma cell line. J. Biol. Chem. 272 (1997) 14349-14355
20. Dethlefsen S.M., Raab G., Moses M.A., Adam R.M., Klagsbrun M., and Freeman M.R. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C. J. Cell Biochem. 69 (1998) 143-153
21. Ozaki M., Itoh K., Miyakawa Y., Kishida H., and Hashikawa T. Protein processing and releases of neuregulin-1 are regulated in an activity-dependent manner. J. Neurochem. 91 (2004) 176-188
22. Suzuki M., Raab G., Moses M.A., Fernandez C.A., and Klagsbrun M. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J. Biol. Chem. 272 (1997) 31730-31737
23. Hinkle C.L., Sunnarborg S.W., Loiselle D., Parker C.E., Stevenson M., Russell W.E., and Lee D.C. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. J. Biol. Chem. 279 (2004) 24179-24188
24. Sahin U., Weskamp G., Kelly K., Zhou H.M., Higashiyama S., Peschon J., Hartmann D., Saftig P., and Blobel C.P. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164 (2004) 769-779
25. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., Ohmoto H., Node K., Yoshino K., Ishiguro H., Asanuma H., Sanada S., Matsumura Y., Takeda H., Beppu S., Tada M., Hori M., and Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8 (2002) 35-40
26. Madarame J., Higashiyama S., Kiyota H., Madachi A., Toki F., Shimomura T., Tani N., Oishi Y., and Matsuura N. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin. Prostate 57 (2003) 187-195
27. Shah B.H., Farshori M.P., and Catt K.J. Neuropeptide-induced transactivation of a neuronal epidermal growth factor receptor is mediated by metalloproteinase-dependent formation of heparin-binding epidermal growth factor. J. Biol. Chem. 279 (2004) 414-420
28. Mayford M., Bach M.E., Huang Y.Y., Wang L., Hawkins R.D., and Kandel E.R. Control of memory formation through regulated expression of a CaMKII transgene. Science 274 (1996) 1678-1683
29. Narisawa-Saito M., Carnahan J., Araki K., Yamaguchi T., and Nawa H. Brain-derived neurotrophic factor regulates the expression of AMPA receptor proteins in neocortical neurons. Neuroscience 88 (1999) 1009-1014
30. Mifune M., Ohtsu H., Suzuki H., Nakashima H., Brailoiu E., Dun N.J., Frank G.D., Inagami T., Higashiyama S., Thomas W.G., Eckhart A.D., Dempsey P.J., and Eguchi S. G protein coupling and second messenger generation are indispensable for metalloproteinase-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor. J. Biol. Chem. 280 (2005) 26592-26599
31. Zhao Y., He D., Saatian B., Watkins T., Spannhake E.W., Pyne N.J., and Natarajan V. Regulation of lysophosphatidic acid- induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase C delta, Lyn kinase and matrix metalloproteinases. J. Biol. Chem. 281 (2006) 19501-19511
32. Morimoto Y., Nishikawa K., and Ohashi M. KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-alpha production. Life Sci. 61 (1997) 795-803
33. 2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture. Proc. Natl. Acad. Sci. USA 95 (1998) 14482-14487
34. Narisawa-Saito M., Iwakura Y., Kawamura M., Araki K., Kozaki S., Takei N., and Nawa H. Brain-derived neurotrophic factor regulates surface expression of alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptors by enhancing the N-ethylmaleimide-sensitive factor/GluR2 interaction in developing neocortical neurons. J. Biol. Chem. 277 (2002) 40901-40910
35. Takenobu H., Yamazaki A., Hirata M., Umata T., and Mekada E. The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascades. J. Biol. Chem. 278 (2003) 17255-17262
36. Karkkainen I., Rybnikova E., Pelto-Huikko M., and Huovila A.P. Metalloproteinase-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol. Cell. Neurosci. 15 (2000) 547-560
37. Schafer B., Marg B., Gschwind A., and Ullrich A. Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival. J. Biol. Chem. 279 (2004) 47929-47938
38. Namba H., Takei N., and Nawa H. Transforming growth factor-alpha changes firing properties of developing neocortical GABAergic neurons by down-regulation of voltage-gated potassium currents. Neuroscience 122 (2003) 637-646
39. Namba H., Nagano T., Iwakura Y., Xiong H., Jourdi H., Takei N., and Nawa H. Transforming growth factor alpha attenuates the functional expression of AMPA receptors in cortical GABAergic neurons. Mol. Cell. Neurosci. 31 (2006) 628-641
40. Yokomaku D., Jourdi H., Kakita A., Nagano T., Takahashi H., Takei N., and Nawa H. ErbB1 receptor ligands attenuate the expression of synaptic scaffolding proteins, GRIP1 and SAP97, in developing neocortex. Neuroscience 136 (2005) 1037-1047